Clinical Trial Update: TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB [Phase 1, Phase 2]

View source ↗

Summary

This trial update reports on the safety and tolerability of low-dose Linezolid in patients with multidrug-resistant and extensively drug-resistant tuberculosis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Drug-resistant Tuberculosis
• Multidrug-resistant Tuberculosis

Drugs mentioned

• Linezolid (Linezolid)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Multi-drug Resistant Tuberculosis, Extensively Drug Resistant Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED